We are live on ! Find out more
CCMU

Cheyne Capital Management (UK) Portfolio holdings

AUM $27.9M
1-Year Est. Return 36.14%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+36.14%
3 Year Est. Return
+35.61%
5 Year Est. Return
+211.68%
10 Year Est. Return
+661.99%
AUM
$57.2M
AUM Growth
+$10.5M
Cap. Flow
+$11.3M
Cap. Flow %
19.68%
Top 10 Hldgs %
46.43%
Holding
72
New
39
Increased
1
Reduced
6
Closed
13

Top Buys

Rank Stock Value
1
CINC
CinCor Pharma, Inc. Common Stock
CINC
+$1.61M
2
XENE icon
Xenon Pharmaceuticals
XENE
+$1.55M
3
RAPT
RAPT Therapeutics
RAPT
+$1.44M
4
PLRX icon
Pliant Therapeutics
PLRX
+$1.38M
5
ALPN
Alpine Immune Sciences Inc
ALPN
+$1.16M

Top Sells

Rank Stock Value
1
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$4.41M
2
CRWD icon
CrowdStrike
CRWD
+$2.04M
3
ATVI
Activision Blizzard
ATVI
+$963K
4
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
+$844K
5
RDNT icon
RadNet
RDNT
+$601K

Sector Composition

Rank Sector Weight
1 Healthcare 41.62%
2 Energy 19.93%
3 Technology 17.14%
4 Materials 10.23%
5 Consumer Discretionary 4.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATVI
1
DELISTED
Activision Blizzard
ATVI
$7.9M 13.8%
103,136
-12,965
-11% -$963K
EXE
2
Expand Energy Corp
EXE
$21.9B
$3.73M 6.51%
39,506
+856
+2% +$84.8K
B
3
Barrick Mining
B
$62.2B
$3.44M 6%
200,000
– –
RDNT icon
4
RadNet
RDNT
$4.84B
$2.1M 3.67%
111,427
-32,171
-22% -$601K
FTCH
5
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$1.97M 3.44%
416,500
-121,218
-23% -$844K
XENE icon
6
Xenon Pharmaceuticals
XENE
$6.32B
$1.68M 2.93%
+42,500
New +$1.55M
SU icon
7
Suncor Energy
SU
$77.7B
$1.47M 2.57%
46,300
– –
OXY icon
8
Occidental Petroleum
OXY
$57B
$1.47M 2.56%
23,300
-302
-1% -$20.6K
RAPT
9
DELISTED
RAPT Therapeutics
RAPT
$1.42M 2.49%
+8,979
New +$1.44M
MSOS icon
10
AdvisorShares Pure US Cannabis ETF
MSOS
$864M
$1.41M 2.47%
202,000
-51,072
-20% -$525K
ALPN
11
DELISTED
Alpine Immune Sciences Inc
ALPN
$1.34M 2.34%
+181,886
New +$1.16M
HTHT icon
12
Huazhu Hotels Group
HTHT
$12.4B
$1.32M 2.3%
+31,000
New +$1.12M
PCVX icon
13
Vaxcyte
PCVX
$7.89B
$1.29M 2.25%
+26,849
New +$1.05M
PLRX icon
14
Pliant Therapeutics
PLRX
$67.5M
$1.28M 2.23%
+66,144
New +$1.38M
NE icon
15
Noble Corp
NE
$6.9B
$1.21M 2.12%
32,100
– –
BILL icon
16
BILL Holdings
BILL
$4.33B
$1.19M 2.08%
10,940
-4,560
-29% -$547K
TECK icon
17
Teck Resources
TECK
$29.5B
$1.06M 1.86%
28,100
– –
SGEN
18
DELISTED
Seagen Inc. Common Stock
SGEN
$1.03M 1.8%
+8,025
New +$1.04M
CVE icon
19
Cenovus Energy
CVE
$54.6B
$1.03M 1.8%
53,000
– –
PNT
20
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$926K 1.62%
+127,090
New +$943K
ISEE
21
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$883K 1.54%
+41,250
New +$880K
BABA icon
22
Alibaba
BABA
$269B
$863K 1.51%
9,800
– –
AEM icon
23
Agnico Eagle Mines
AEM
$72.6B
$853K 1.49%
16,400
– –
CINC
24
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$830K 1.45%
+67,557
New +$1.61M
CRC icon
25
California Resources
CRC
$4.75B
$817K 1.43%
18,785
– –
1
2 3

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return
TCM
TORQ Capital Management Hong Kong $38.1M AUM 2.81% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
AMC
AKKR Management Company Menlo Park, California $42.5M AUM 123.1% 1-Year Est. Return
P
Pariax Newport Beach, California $44.3M AUM 12.57% 1-Year Est. Return
AOGP
Addition One General Partner New York $45.7M AUM
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return

Cheyne Capital Management (UK)'s Q4 2022 Portfolio in Review

As of Q4 2022, Cheyne Capital Management (UK) held 72 positions worth $57.2M, up 22% from $46.8M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cheyne Capital Management (UK) deployed $11.3M of net new capital in Q4 2022, opening 39 new positions and adding to 1 existing holding. Its largest new stake was CinCor Pharma, Inc. Common Stock: 67,557 shares worth $830K.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 6.4% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Activision Blizzard, an estimated $963K trimmed.

  • Cheyne Capital Management (UK)'s largest Q4 2022 buy was CinCor Pharma, Inc. Common Stock: 67,557 shares worth $830K.
  • Cheyne Capital Management (UK) added most to Expand Energy Corp in Q4 2022, an estimated $84.8K increase.
  • Cheyne Capital Management (UK)'s biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $963K.
  • Cheyne Capital Management (UK) fully exited Switch, Inc. Class A Common Stock in Q4 2022, selling an estimated $4.41M.
  • Cheyne Capital Management (UK)'s ten largest holdings make up 46% of its $57.2M portfolio in Q4 2022.
  • Cheyne Capital Management (UK) opened 39 new positions and closed 13 in Q4 2022.
  • Cheyne Capital Management (UK)'s portfolio value rose 22% quarter-over-quarter to $57.2M.

Based on Cheyne Capital Management (UK)'s 13F filing for Q4 2022, filed 10 Feb 2023.